Literature DB >> 21416237

Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan.

Yu-Chao Lin1, Shinn-Jye Liang, Yi-Heng Liu, Wu-Huei Hsu, Chuen-Ming Shih, Fung-Chang Sung, Wei Chen.   

Abstract

A previous study, with relatively small number of patients, showed that prior Mycobacterium tuberculosis (TB) may precipitate SLE in patients from endemic areas. The purpose of the study was to investigate the relationship between prior TB infection and systemic lupus erythematosus (SLE) from the National Health Insurance Research Database (NHIRD) in Taiwan. Cases of SLE and TB were identified from the NHIRD with corresponding ICD-9 codes 710.0 and 011-018, respectively, from January 2000 to December 2008. A total of 2,721 cases of SLE and 10,823 control subjects were included in data analysis. The average annual incidence rate was 8.1 per 100,000. The annual incidence rates of SLE decreased from 6.38 per 100,000 to 2.55 per 100,000 during 2000-2008. Compared with the control subjects, SLE patients were more likely to be white collar workers (P = 0.0005), reside in highly urbanized areas (P = 0.0140), and have higher incomes (P = 0.0088). TB was much more prevalent in SLE patients than in the control subjects (1.8 vs. 0.9%, P < 0.001). The mean time interval between diagnosis of TB and SLE was 45.58 ± 39.0 months. On multivariate analysis, TB was the greatest potential risk factor for precipitating SLE (OR = 2.11, 95% CI = 1.49-3.00). In addition, patients with co-existing TB and DM had a higher risk of SLE than the control group (OR = 3.91, 95% CI 1.84-8.31). In conclusion, this study suggests that there is an increased risk of precipitating SLE among patients with TB in Taiwan from a nationwide health insurance research dataset. Mycobacterial infections could trigger autoimmune diseases in experimental studies. Furthermore, a study with relatively small number of patients revealed that prior TB may precipitate SLE in patients from endemic areas. There is an increased risk of precipitating SLE among patients with TB in Taiwan from a nationwide health insurance research dataset during a 9-year period.

Entities:  

Mesh:

Year:  2011        PMID: 21416237     DOI: 10.1007/s00296-011-1847-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Tuberculosis treatment in complex emergencies: South Sudan.

Authors:  Arjan Hehenkamp; S Hargreaves
Journal:  Lancet       Date:  2003-12       Impact factor: 79.321

2.  Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan.

Authors:  Y-M Chiu; C-H Lai
Journal:  Lupus       Date:  2010-07-20       Impact factor: 2.911

Review 3.  Drug-induced lupus erythematosus.

Authors:  Piercarlo Sarzi-Puttini; Fabiola Atzeni; Franco Capsoni; Ennio Lubrano; Andrea Doria
Journal:  Autoimmunity       Date:  2005-11       Impact factor: 2.815

4.  Epidemiology of systemic lupus erythematosus in rural Wisconsin.

Authors:  A L Naleway; M E Davis; R T Greenlee; D A Wilson; D J McCarty
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 5.  Mycobacterium tuberculosis in Taiwan.

Authors:  Po-Ren Hsueh; Yung-Ching Liu; Jen So; Cheng-Yi Liu; Pan-Chyr Yang; Kwen-Tay Luh
Journal:  J Infect       Date:  2005-10-10       Impact factor: 6.072

Review 6.  Immunologic and genetic factors in autoimmune diseases.

Authors:  Y Shoenfeld; R S Schwartz
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

Review 7.  Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade.

Authors:  George K Bertsias; Jane E Salmon; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

8.  Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis.

Authors:  Y Shoenfeld; Y Vilner; A R Coates; J Rauch; G Lavie; D Shaul; J Pinkhas
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

9.  The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea.

Authors:  J E Yun; S W Lee; T H Kim; J B Jun; S Jung; S C Bae; T Y Kim; D H Yoo
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

10.  Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.

Authors:  J Holoshitz; A Matitiau; I R Cohen
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more
  11 in total

1.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

2.  Miliary tuberculosis mimicking systemic lupus erythematosus flare.

Authors:  Fatehi Elzein; Ahmed Elzein; Nazik Mohammed; Ramiz Alswailem
Journal:  Respir Med Case Rep       Date:  2018-09-11

3.  Increased risk of subsequent benign prostatic hyperplasia in non-Helicobacter pylori-infected peptic ulcer patients: a population-based cohort study.

Authors:  Chu-Wen Fang; Chun-Hao Chen; Kun-Hung Shen; Wen-Chi Yang; Chih-Hsin Muo; Shih-Chi Wu
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

4.  Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.

Authors:  Jun Won Park; Jeffrey R Curtis; Hajeong Lee; Jung-Kyu Lee; Yeong Wook Song; Eun Bong Lee
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

5.  Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies.

Authors:  Sreeram V Ramagopalan; Raph Goldacre; Andrew Skingsley; Chris Conlon; Michael J Goldacre
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

Review 6.  Infection and Lupus: Which Causes Which?

Authors:  Sarah Doaty; Harsh Agrawal; Erin Bauer; Daniel E Furst
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.686

7.  First report of multi-drug resistant tuberculosis in a systemic lupus erythematosus patient.

Authors:  Kunchok Dorjee; Kerry L Dierberg; Tsetan D Sadutshang; Arthur L Reingold
Journal:  BMC Res Notes       Date:  2015-08-06

8.  Patterns of ambulatory medical care utilization and rheumatologist consultation predating the diagnosis of systemic lupus erythematosus: a national population-based study.

Authors:  Ning-Sheng Lai; Tzung-Yi Tsai; Malcolm Koo; Kuang-Yung Huang; Chien-Hsueh Tung; Ming-Chi Lu
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

9.  Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study.

Authors:  Yi-Da Wu; Ching-Heng Lin; Wen-Cheng Chao; Tsai-Ling Liao; Der-Yuan Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

10.  Prevalence and Associated Factors of Lupus in the United States: Third National Health and Nutritional Examination Survey (NHANES III).

Authors:  Xiaomei Leng; Jin Xia; Xiaofeng Zeng; Yiqing Song
Journal:  Front Med (Lausanne)       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.